SoranusMED

Neuromodulation
Wearables

SoranusMED is a medical device company developing non-invasive and minimally invasive solutions for pelvic floor disorders affecting women and men. Its portfolio spans urogynecology and urology, including mesh-free surgical treatment for stress urinary incontinence, wearable neuromodulation for overactive bladder, and a developing surgical device for pelvic organ prolapse.

Visit soranusmed.com ↗

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

Recent highlights

SoranusMED’s publicly described work centers on pelvic floor disorders in urogynecology and urology, with products spanning both surgical and non-invasive treatment approaches. Its portfolio includes a mesh-free surgical approach for female stress urinary incontinence, the SmartUric wearable system for overactive bladder, and a surgical device for pelvic organ prolapse that remains in development. The company emphasizes collaboration among academic surgeons, medical advisors, engineers, and regulatory specialists, indicating an effort to combine clinical validation with device development. As a result, the company’s most recent commercial and clinical progress cannot be dated confidently, and there is insufficient evidence to characterize an acceleration or slowdown in activity.

Market position

SoranusMED operates at the intersection of urogynecology, urology, medical devices, pelvic health, and digital therapeutics. Its stated differentiation is the combination of a mesh-free, natural-tissue surgical approach for stress urinary incontinence with a physician-prescribed wearable neuromodulation system for overactive bladder. That combination gives the company a broader modality mix than a single-procedure device developer, while SmartUric’s intended home-use model could support treatment outside traditional procedural settings. The company also targets pelvic organ prolapse through a device still in development, extending its addressable clinical scope. The available profile does not identify named competitors, comparative clinical outcomes, regulatory approvals, reimbursement status, or commercial adoption, so relative market position cannot be ranked reliably against established urogynecology device manufacturers, neuromodulation providers, or digital pelvic-health companies. Its competitive potential therefore rests on whether the VACS approach and SmartUric can demonstrate safety, efficacy, adherence, and physician acceptance.

Growth & opportunities

SoranusMED’s product roadmap suggests a progression from clinical insight and surgical innovation toward a portfolio covering multiple pelvic floor conditions. The VACS and related SoranusMED mesh-free device address female stress urinary incontinence through a natural-tissue surgical approach. SmartUric extends the portfolio into non-invasive treatment, using wearable transcutaneous posterior tibial nerve neuromodulation for overactive bladder and incorporating digital tools intended to support monitoring and adherence. A further surgical device for pelvic organ prolapse indicates continued expansion within urogynecology, although it is described as being in development. The current evidence supports a product-development trajectory rather than a quantified scale-up story. Future progress will likely depend on clinical validation, regulatory execution, physician adoption, manufacturing readiness, and the ability to demonstrate sustained patient use for SmartUric.

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

What makes SoranusMED distinct

reccy insights

What makes SoranusMED distinct

01Focuses on significant unmet needs in urogynecology and urology, serving large patient populations with pelvic floor disorders.
02Developed a mesh-free, natural-tissue surgical approach for female stress urinary incontinence.
03Combines clinical insight from academic surgeons and medical advisors with engineering and medical technology expertise.
04SmartUric is designed as a wearable, non-invasive, physician-prescribed system for home-based overactive bladder therapy.
05Uses a multidisciplinary, patient-centered approach spanning clinical development, engineering, regulatory planning, and strategic partnerships.

Technology & products3

Technology & products

SmartUric
A physician-prescribed wearable, non-invasive transcutaneous posterior tibial nerve neuromodulation system intended for home-based overactive bladder therapy.
SoranusMED Mesh-Free Surgical Device
A surgical device supporting a mesh-free, natural-tissue approach to female stress urinary incontinence based on Vaginal Arcocolposuspension.
Pelvic Organ Prolapse Surgical Device
A surgical device for pelvic organ prolapse treatment that is in development.

Similar companies

Show all 6 companies

About SoranusMED

Products: SmartUric, SoranusMED Mesh-Free Surgical Device, Pelvic Organ Prolapse Surgical Device
Focus areas: Medical devices, urogynecology, urology, pelvic health, women's health, neuromodulation, wearables, minimally invasive surgery
Headquarters: Izmir, Turkey